|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Unrealized foreign currency loss | |||||
| Non-cash operating lease expense | |||||
| Amortization expense of finance leases | |||||
| Bad debt expense (benefit) | |||||
| Stock-based compensation expense | |||||
| Amortization of intangible assets | |||||
| Deferred tax provision (benefit) | |||||
| Impairment of right-of-use and long-lived assets | |||||
| Change in fair value of contingent consideration liability | |||||
| Change in fair value of warrant liability | |||||
| Loss on extinguishment of debt | |||||
| Non-cash interest expense on senior secured convertible notes | |||||
| Accretion of debt discount | |||||
| Change in fair value of financing derivatives | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued expenses, and other liabilities | |||||
| Contract liabilities and customer advances | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capitalized internal-use software costs | |||||
| Purchases of property and equipment | |||||
| Cash and restricted cash acquired from acquisition | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from insurance financing | |||||
| Payments for dividends on convertible redeemable preferred stock | |||||
| Principal payment and extinguishment costs | |||||
| Convertible senior notes | |||||
| Notes Payable, Other Payables | |||||
| Proceeds from borrowings on revolving line of credit | |||||
| Proceeds from issuance of convertible redeemable preferred stock, net of issuance costs | |||||
| Proceeds from secured term loan | |||||
| Payments of line of credit | |||||
| Principal payments of term loan | |||||
| Payment of financing and debt issuance costs | |||||
| Contingent consideration payment at initial value | |||||
| Payment of preferred stock and common stock issuance costs | |||||
| Principal payments on insurance financing | |||||
| Principal payments on finance leases | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow disclosures: | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Operating cash flows from operating leases | |||||
| Operating cash flows from finance leases | |||||
| Supplemental non-cash activities: | |||||
| Fair value of Series C convertible redeemable preferred stock and Common stock in connection with the Recapitalization Transaction | |||||
| Present value of fixed payable recognized in connection with Recapitalization Transaction | |||||
| Accrued preferred stock and common stock issuance costs | |||||
| Change in accounts payable and accrued expenses related to capital expenditures | |||||
| Right-of-use assets obtained in exchange for finance lease liabilities | |||||
| Settlement of restricted stock unit liability | |||||
| Modification of operating right-of-use assets | |||||
| Convertible redeemable preferred stock dividends accrued but not yet paid | |||||
| Issuance of convertible redeemable preferred stock (related parties) | |||||
| Interest paid in Common Stock | |||||
| Conversion shares issued as extinguishment cost on senior secured convertible notes | |||||
| Fair value of contingent consideration recognized upon closing of acquisition | |||||
| Accrued debt issuance costs | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...